- Journal List >
- F1000 Med Rep >
- v.4; 2012 >
- PMC3515944
F1000 Med Rep. 2012; 4: 24.
Published online 2012 December 3. doi: 10.3410/M4-24
PMCID: PMC3515944
Prevention of atopic dermatitis
Abstract
Atopic dermatitis now affects one in five children, and may progress to asthma and hay fever. In the absence of effective treatments that influence disease progression, prevention is a highly desirable goal. The evidence for most existing disease prevention strategies, such as avoidance of allergens and dietary interventions, has been unconvincing and inconsistent. Fresh approaches to prevention include trying to induce tolerance to allergens in early life, and enhancing the defective skin barrier to reduce skin inflammation, sensitisation and subsequent allergic disease. Early and aggressive treatment of atopic dermatitis represents another possible secondary prevention strategy that could interrupt the development of autoimmunity, which may account for atopic dermatitis persistence. Large scale and long term randomized controlled trials are needed to demonstrate that these ideas result in clinical benefit.
Prevention of atopic dermatitis
Centre of Evidence Based Dermatology, University of Nottingham, King’s Meadow Campus, Lenton Lane, Nottingham, NG7 2NR, UK
Nottingham University Hospitals NHS Trust, Dermatology Department, Queen’s Medical Centre Campus, Derby Road, Nottingham, NG7 2RB, UK
Department of Dermatology, Oregon Health & Science University, Portland, Oregon, OR 97239 USA
Nottingham University Hospitals NHS Trust, Dermatology Department, Queen’s Medical Centre Campus, Derby Road, Nottingham, NG7 2RB, UK
Department of Dermatology, Oregon Health & Science University, Portland, Oregon, OR 97239 USA
F1000 Med Reports2012, 4:24 (doi: 10.3410/M4-24)
Published: 03 Dec 2012
© 2012 Faculty of 1000 Ltd
No comments:
Post a Comment